Preparation for rapidly entering plateau gastrointestinal dysfunction as well as preparation method and application thereof
By using supercritical carbon dioxide extraction and microneedle patch technology to extract the herbal composition of Buzhong Yiqi Fang (补中益气方), the treatment challenge of gastrointestinal dysfunction in high-altitude environments has been solved, achieving intestinal flora regulation and symptom improvement, and enhancing patients' ability to adapt to high altitudes.
Patent Information
- Application Number
- CN202511817551.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-04
- Publication Date
- 2026-02-13
AI Technical Summary
Existing technologies for treating rapidly progressive gastrointestinal dysfunction in high-altitude environments are not effective in addressing the stress of high-altitude environments, are prone to relapse after discontinuation of medication, and fail to effectively regulate the intestinal flora.
The active ingredients of the Buzhong Yiqi formula are extracted using supercritical carbon dioxide fluid extraction technology and prepared into umbilical patches or oral-umbilical patch combination preparations. Combined with microneedle patches, they act directly on acupoints to regulate intestinal flora and gastrointestinal function.
It effectively regulates the gut microbiota, reverses 14 metabolites, improves symptoms of gastrointestinal dysfunction, enhances patients' ability to adapt to high-altitude environments, and reduces drug toxicity and side effects.
Smart Images

Figure CN121513089A_ABST
Abstract
Description
TECHNICAL FIELD
[0001] The application belongs to the technical field of pharmaceutical preparations, and particularly relates to a preparation for gastrointestinal dysfunction in rapid ascent to high altitude and a preparation method and application thereof. BACKGROUND
[0002] Functional gastrointestinal disease (IBS) is one of the common functional gastrointestinal diseases in clinical practice, with an incidence of 0.8%-5.6%, accounting for 30%-50% of the outpatient volume of the gastroenterology department, and mostly affecting young adults. The causes and mechanisms of the disease have not been fully elucidated, and most scholars believe that it is related to factors such as intestinal motility disorder, increased visceral sensitivity, abnormal nerve function, and mental changes. The current prevalence of IBS is about 12.1%, and its main symptom is recurrent abdominal pain accompanied by changes in bowel habits (Rome IV criteria). IBS can reduce the quality of life of patients, and genetic, dietary, intestinal flora, intestinal endocrine cells, and low-grade inflammation may play a major physiological and pathological role. The intestinal bacterial diversity (ecological imbalance) of IBS patients is lower than that of healthy subjects. Changes in the intestinal flora of experimental animals lead to gastrointestinal motility disorders, visceral hypersensitivity, changes in intestinal permeability, and changes in behavior, which can explain the abdominal symptoms of IBS. Compared with healthy people, IBS patients have lower levels of actinomycetes (including bifidobacteria) in their feces and higher levels of Bacteroidetes in their mucosa. This pattern of flora change also occurs in the flora changes of people from plains to high altitudes.
[0003] The intestinal flora begins to establish from birth and changes continuously with growth and development, food and drug intake, and the environment. The special environment of high altitude, including low pressure, low oxygen, large diurnal temperature difference, strong winds, dryness, and strong ultraviolet radiation, determines the unique ecological environment of animals, plants, and microorganisms at high altitudes, which is completely different from that at low altitudes. Compared with the plains native Han nationality, the abundance of amino acid coccobacillus and butyrate clostridium in the intestinal flora of the high-altitude migrant Han nationality significantly increases, while the abundance of oscillibacter and sutterella significantly decreases; compared with the high-altitude native Tibetan nationality, the abundance of actinomycetes and bacteroides in the intestinal flora of the high-altitude migrant Han nationality significantly increases, while the abundance of kristensen and spirochaetes significantly decreases; and compared with the plains native Han nationality, the abundance of butyric vibrio and lactobacillus in the intestinal flora of the high-altitude native Tibetan nationality significantly increases, while the abundance of Alistipes significantly decreases. These differences may be due to genetic, dietary, and altitude differences. Studies on different altitude native Tibetans have shown that, excluding the effects of other factors such as diet, the difference in intestinal flora is closely related to altitude. This suggests that a variety of metabolic products and other physicochemical effects of different intestinal flora compositions are important factors in healthy living at high altitudes.
[0004] Some studies have found that the intestinal flora of Han people changes to different degrees after entering the plateau for 4 days, and the flora structure gradually converges with the local population over time. A large number of different studies suggest that the intestinal flora in the plateau environment increases the risk of cardiovascular accidents, pulmonary edema, intestinal dysfunction, depression and other critical diseases on the plateau through hypoxia-inducible factor (HIF), endotoxin (LPS) and other chemical factors, changes in flora structure, increased permeability and other physical factors, and other risk factors.
[0005] For gastrointestinal dysfunction on the plateau, Western medicine still adopts a treatment method mainly for symptomatic treatment, such as giving antidiarrheal agents, intestinal motility inhibitors, astringents, adsorbents and other treatment methods. Although it has certain curative effect, it is easy to repeat after stopping the drug without addressing the root cause of the stress of the plateau environment. SUMMARY
[0006] To solve the above technical problems, the present application provides a preparation for gastrointestinal dysfunction after sudden entry into the plateau, a preparation method and application thereof.
[0007] The technical scheme adopted by the present application is:
[0008] A preparation for gastrointestinal dysfunction after sudden entry into the plateau, the composition comprising Astragalus 25-35g, Dangshen 10-20g, Baizhu 10-20g, Dangui 8-12g, Shengma 8-12g, Chaihu 8-12g, Chenpi 8-12g, Zhigancao 8-12g, and the preparation comprising active ingredients extracted from the composition.
[0009] Preferably, the active ingredients of the composition are prepared into an umbilical patch preparation or an oral-umbilical patch combined preparation.
[0010] A method for preparing a preparation for gastrointestinal dysfunction after sudden entry into the plateau, the composition raw materials are weighed and mixed, and then concentrated to obtain a formula granule;
[0011] Or the composition raw materials are weighed and mixed, and then pulverized to obtain a formula effective ingredient by supercritical carbon dioxide fluid extraction, and the extraction product is mixed with excipients to prepare an oral preparation.
[0012] Preferably, the extraction product is prepared into an umbilical patch preparation.
[0013] Preferably, the extraction product is mixed with a gel to prepare a microneedle patch.
[0014] The preparation for gastrointestinal dysfunction after sudden entry into the plateau is used for the preparation of a drug for gastrointestinal dysfunction after sudden entry into the plateau.
[0015] Preferably, it can regulate the intestinal flora.
[0016] The application has the advantages and positive effects that the Buzhong Yiqi formula can bidirectionally regulate small intestinal peristalsis, has inhibitory effect when intestinal peristalsis is hyperactive, and has excitatory effect when tension decreases; 14 of 24 different metabolites can be effectively reversed, metabolites such as unsaturated fatty acids and amino acids are regulated, and disease symptoms are improved; the traditional Chinese medicine composition contains a large amount of saccharides, glycosides and various trace elements, has a prebiotic effect, and has a good promoting effect on the growth of probiotics.
[0017] The active ingredients of the Buzhong Yiqi formula are extracted, and a microneedle patch is prepared, which can be directly used for navel sticking and can be used for gastrointestinal function disorder caused by rapid entry into a plateau area. BRIEF DESCRIPTION OF DRAWINGS
[0018] Figure 1 Process diagram of supercritical carbon dioxide fluid extraction technology;
[0019] Figure 2 Microneedle patch product;
[0020] Figure 3 Transdermal effect of microneedle;
[0021] Figure 4 HE staining diagram of small intestinal tissue of mice in each group;
[0022] Figure 5 Differential function display of fecal intestinal flora T between groups;
[0023] Figure 6 Differential confidence display of fecal intestinal flora T between groups;
[0024] Figure 7 Functional annotation volcano plot of fecal intestinal flora T. DETAILED DESCRIPTION
[0025] The embodiments of the application will be described below with reference to the accompanying drawings.
[0026] The application relates to a preparation for gastrointestinal function disorder caused by rapid entry into a plateau area and a preparation method and application thereof, and is based on the Buzhong Yiqi formula. Effective ingredients in a drug composition are extracted by supercritical carbon dioxide fluid extraction technology, and a reagent or reagent composition suitable for oral administration and / or a patch is further prepared. The reagent or reagent composition is suitable for gastrointestinal function disorder caused by rapid entry into a plateau area.
[0027] The Buzhong Yiqi Formula is a representative formula for invigorating qi and strengthening the spleen. It uses sweet and warm herbs to invigorate the middle jiao and raise yang, the sweet and warm properties of which are just right to resist the thin air and external cold of the high-altitude environment. Astragalus membranaceus (Huangqi) is sweet and slightly warm, entering the spleen and lung meridians, invigorating the middle jiao and raising yang to consolidate the exterior. It is combined with ginseng to replenish insufficient primordial qi, prepared licorice root to invigorate the spleen and stomach and generate qi and blood, and atractylodes macrocephala (Baizhu) to invigorate qi and strengthen the spleen, working with astragalus to enhance the effect of invigorating the middle jiao and strengthening qi. Angelica sinensis (Danggui) nourishes blood and harmonizes the nutritive qi, working with ginseng and astragalus to invigorate qi and nourish blood. Tangerine peel (Chenpi) regulates qi and harmonizes the stomach, and also disperses the stagnation caused by the sweet herbs. Since the clear qi in the stomach sinks, Cimicifuga foetida (Shengma) and Bupleurum chinense (Chaihu), two herbs with clear qi and mild taste, are used to raise the stomach qi to promote growth. The combined effects of these herbs replenish qi deficiency and raise sunken qi, thus replenishing primordial qi and allowing clear yang to rise.
[0028] The traditional Chinese medicine composition includes 30g of Astragalus membranaceus, 15g of Codonopsis pilosula, 15g of Atractylodes macrocephala, 10g of Angelica sinensis, 10g of Cimicifuga foetida, 10g of Bupleurum chinense, 10g of Citrus reticulata peel, and 10g of Glycyrrhiza uralensis (processed with honey). The herbal ingredients are weighed according to the formula, decocted, and concentrated into granules. The prepared granules can be directly used to prepare oral formulations.
[0029] Traditional Chinese medicine compositions can also have their active substances extracted using supercritical carbon dioxide fluid extraction (SFE-CO2) technology. The herbal ingredients are weighed and mixed according to the formula, then pulverized before use. Through SFE-CO2 technology, under high density and high pressure in a supercritical state, the separation of the supercritical fluid (CO2) from the natural product being tested is achieved by changing the temperature and pressure. Based on the solubility of the supercritical fluid, compounds of different polarities, boiling points, and molecular weights are selectively extracted, protecting the effective components of the traditional Chinese medicine from damage, ensuring and improving product quality, and maximizing the preservation of volatile, lipid-soluble, and heat-sensitive active ingredients.
[0030] In some embodiments of the present invention, such as Figure 1 As shown, the supercritical carbon dioxide fluid extraction technology includes the following steps: The formulated granular powder is added to the extraction tank, sealed, and the device is then turned on. CO2 is pumped into the extraction tank via a filter using a high-pressure pump. Extraction parameters are set, and ethanol is added as a co-extractant. The ethanol solution containing the drug components is depressurized and enters the separation tank for drug-liquid separation and extraction. The CO2 is circulated using a high-pressure pump. Specifically, the extraction temperature in the fixed extraction tank is 45℃, and the pressure in the extraction tank is 20MPa; the separation pressure is 4.5MPa, the separation temperature is 35℃, the flow rate is 20kJ / h, the flow rate of the co-extractant ethanol is 2L / h, and the overall extraction time is 1h.
[0031] The active substances in the prepared traditional Chinese medicine composition can be mixed with suitable excipients to prepare oral medications in different dosage forms. It can also be prepared as a patch.
[0032] The patch defined in Western medicine is a thin sheet-shaped preparation made of drugs and suitable materials for sticking on the skin to produce systemic or local effects. It has the characteristics of avoiding first-pass effect, reducing the number of administrations, and improving patient compliance. The patch can be divided into adhesive dispersion type, peripheral adhesive matrix type, and reservoir type. Because of the characteristics of thin skin and rich subcutaneous umbilical vascular around the umbilical, the umbilical part is often used as the use site of the patch. The patch of traditional Chinese medicine combines the meridian theory of traditional Chinese medicine and is mostly transdermal administration at acupoints. After the drug is applied to the corresponding acupoint, the drug can be directly absorbed through the local skin acupoint. Since it is not taken orally, the liver first-pass effect and the inactivation of drug components in the gastrointestinal tract can be avoided, thereby better exerting the drug effect and at the same time reducing the toxic and side effects of the drug. Acupoint sticking, drug transmission through human meridians can affect multiple physiological functions and produce mutual synergistic effects, causing physiological amplification effect.
[0033] In some embodiments of the present application, the active ingredients of the prepared traditional Chinese medicine composition can be added to the gel to prepare a microneedle patch. For example, EFL microneedles (EFL-VDM-001, EFL-MMN-600) are prepared by transdermal technology selection, and a photocurable hydrogel methacrylated gelatin (GelMA) is used. The study of drug penetration through the skin is the key to the development of transdermal drug delivery systems. In addition, the addition of a suitable concentration of transdermal penetration enhancer can further enhance the transdermal penetration of the drug.
[0034] According to the characteristics of the Buzhong Yiqi Decoction, an in vitro mouse skin is used as a penetration barrier, and a Franz diffusion cell system is used to establish an in vitro transdermal absorption experimental method. The effects of penetration enhancers such as azone, propylene glycol, and new penetration enhancers Transcutol P and Labrosal on the transdermal absorption of effective ingredients in the Buzhong Yiqi umbilical patch are investigated at a dosage of 0.5% to 5%.
[0035] The Buzhong Yiqi Decoction can bidirectionally regulate small intestinal peristalsis, has an inhibitory effect when intestinal peristalsis is hyperactive, and has an excitatory effect when tension decreases. The Buzhong Yiqi Decoction can also regulate the degree of intestinal cell junction and protect the intestinal barrier. In terms of treating IBS with the Buzhong Yiqi Decoction, through metabolomics research on gastrointestinal motility disorder rats, it is found that the Buzhong Yiqi Decoction can effectively reverse 14 of 24 differential metabolites, regulate unsaturated fatty acid and amino acid metabolites, and improve disease symptoms. Most of these metabolites are metabolic products of certain intestinal flora.
[0036] In terms of intervention of the intestinal flora by the Buzhong Yiqi recipe, the traditional Chinese medicine composition contains a large amount of saccharides, glycosides and various trace elements, has a prebiotic effect and has a good promoting effect on the growth of probiotics. In addition, the Buzhong Yiqi recipe also has a regulating effect on the immune function of the human body and is beneficial to the balance of the intestinal flora. The Buzhong Yiqi recipe plus-minus recipe combined with the Shenque acupoint and the bilateral large intestine acupoints has a significant effect on the treatment of outlet obstructive constipation by adjusting the intestinal flora, increasing the number of bifidobacterium and lactic acid bacteria and reducing the number of enterobacterium and enterococcus.
[0037] The scheme of the present application is described below in combination with the drawings, wherein the experimental methods not specifically described in the operation steps are performed according to the corresponding product instructions. The instruments, reagents and consumables used in the examples can be purchased from commercial companies if not specifically stated.
[0038] Example 1: Preparation of oral preparation
[0039] 30g of Huangqi, 15g of Dangshen, 15g of Baishu, 10g of Dangui, 10g of Shengma, 10g of Chaihu, 10g of Chenpi and 10g of Zhigancao were weighed, respectively, and mixed and crushed. The powder was put into an extraction cylinder, sealed and started. CO2 was sent into the extraction cylinder through a filter after passing through a high-pressure pump. The extraction parameters were set, the extraction temperature of the extraction cylinder was fixed at 45℃, the pressure of the extraction cylinder was 20MPa, the separation pressure was 4.5MPa, the separation temperature was 35℃, the flow rate was 20k / h and the flow rate of ethanol as the co-extraction agent was 2L / h. Ethanol was added as the co-extraction agent and extraction was performed. The ethanol solution containing the effective components of the medicine entered the separation cylinder after pressure reduction and the medicine liquid was separated and extracted. The overall extraction time was 1h.
[0040] The extracted product was mixed with excipients, 1:4 of dextrin was added according to the mass ratio, and the oral preparation Buzhong Yiqi granules was prepared.
[0041] Example 2: Preparation of navel patch
[0042] 2.1 Preparation of microneedle patch
[0043] The extracted product prepared in Example 1 was prepared into a microneedle patch. EFL microneedle (EFL-VDM-001, EFL-MMN-600) was used, and a photocured hydrogel methacrylated gelatin (GelMA) was used. The specific steps are as follows.
[0044] The 5% (w / v) hydrogel precursor solution was added dropwise with the traditional Chinese medicine components prepared in Example 1 at 5%; the precursor solution was placed in a microneedle mold, and deaeration was performed under negative pressure at room temperature (repeated 2-3 times); heating was performed in an oven at 30-35°C, and multiple heating and concentration were performed; UV 405nm light curing was performed; a composite base film was prepared, and a 20% (w / v) PVA solution was added dropwise; heating and drying were performed in an oven at 30-35°C for >12h; the microneedle was demolded, and a microneedle patch containing the effective components of the traditional Chinese medicine composition was obtained. The microneedle patch, the finished product, is shown in Figure 2 . .
[0045] The prepared microneedle patch can be directly used as an omphalotic patch. The penetration depth of the microneedle patch was detected, and the results are shown in Figure 3 . The microneedle patch can act on a depth of 450μm, and when used as an omphalotic patch, the traditional Chinese medicine composition can quickly take effect.
[0046] 2.2 Safety experiment of omphalotic patch
[0047] Eight New Zealand rabbits were numbered by body weight from low to high, and then divided into two groups, i.e. intact skin experimental group and intact skin control group, by using a random number table. Each group had 4 rabbits. After the back was depilated, the omphalotic patch was applied for 24h; the intact skin control group: after the back was depilated, the base patch was applied for 24h.
[0048] Skin irritation experiment observation: 1, 24, 48, and 72h after the drug was eluted, the skin of the depilated area of the experimental rabbits was observed continuously under a microscope. According to the drug toxicology standard, the “Skin Irritation Reaction Scoring Standard” was used for scoring, and the average score was calculated by the formula “average score of irritation = (total score of erythema formation + total score of edema formation) / total number of animals”. According to the “Skin Irritation Intensity Evaluation Standard”, the skin irritation of the plateau omphalotic patch ointment was determined. Results: After the microneedles were removed, mild erythema appeared in both groups, and the scores of both groups were less than 0.5, indicating no irritation.
[0049] Skin acute toxicity experiment observation: observation was started immediately after the drug was eluted, and was continuously performed for 14d, 2 times / day. Observation indexes: according to the drug toxicology research method, the “Observation Index Table of Experimental Animals” was used to observe the changes of the skin, hair, diet, excretion, respiration, eyes and mucous membrane, mental state, limb movement, and death of the experimental rabbits. If death occurred, autopsy and macroscopic observation were performed, and when there were macroscopically visible lesions, histopathological examination was performed. The body weight was measured 7d and 14d after administration. Results: There were no obvious changes in the observation indexes of the animals in both groups, and the body weight of the animals before and after the experiment was 4.87±2.13, 5.03±1.29, and no animals died.
[0050] The above experiments prove that the microneedle patch has excellent biological safety.
[0051] Example 3: Effect of the Buzhong Yiqi preparation on hypoxic mice
[0052] Fifty mice were divided into five groups. The first group was the control group and was not treated. The other four groups were treated with the Rhodiola group (0.078 / kg.d), the Buzhong Yiqi Decoction low-dose group (4.78 / kg.d), the Buzhong Yiqi Decoction medium-dose group (9.56 / kg.d), and the Buzhong Yiqi Decoction high-dose group (19 / kg.d), respectively. The Buzhong Yiqi Decoction was the extraction product prepared in Example 1.
[0053] After 14 days of gavage treatment, the hypoxic model of mice was prepared. The 14-day mice treated with the Buzhong Yiqi Decoction by gavage were subjected to acute anoxic model preparation in the anoxic bottle. Nitrogen was filled into the anoxic bottle, and the survival time of the mice was shown in Table 1.
[0054] Table 1: Effect of different doses of the Buzhong Yiqi Decoction on the survival time of hypoxic mice (n=15)
[0055] As shown in the table, the Buzhong Yiqi Decoction was better than Rhodiola in the effect on the survival time of mice, and could better improve the adaptability of mice in the hypoxic environment.
[0056] The mice treated by the foregoing gavage method were subjected to hypoxic model construction. Hypoxic mixed gas was filled into the anoxic bottle, including 10% oxygen, 5% carbon dioxide, and 85% nitrogen, to create a hypoxic environment. After 3 days of action, the mice were sacrificed, and the changes in the small intestine were observed by HE staining. The results are shown in Figure 4 Compared with the normal group, the villi of the model group were lighter and broken, the epithelium was lost, and the inflammatory cells were increased and infiltrated. Compared with the model group, the damage degree of the Rhodiola group was reduced, and the protection degree of the Buzhong Yiqi Decoction group from the low-dose medium-dose to the high-dose was gradually increased.
[0057] The hypoxic mice were sacrificed, and the small intestinal tissue was homogenized for detection of superoxide dismutase (SOD), reduced glutathione (GSH), and malondialdehyde (MDA). Compared with the control group, the indicators of the Rhodiola group and the Buzhong Yiqi Decoction group were increased, and the SOD of the Buzhong Yiqi Decoction group was significantly increased.
[0058] Table 2: Effect of different doses of the Buzhong Yiqi Decoction on MDA, GSH, and SOD of mice (n=15)
[0059] It was found that the pre-use of Buzhong Yiqi decoction can effectively prolong the survival time of mice in anaerobic environment; in the hypoxic and anoxic model, the intestinal pathological damage was significantly improved; the biochemical indicators such as SOD, MDA and GSH were improved to different degrees, especially the expression of SOD in the Buzhong Yiqi group was 5-10 times higher than that in the Rhodiola group.
[0060] Example 4: Application of Buzhong Yiqi preparation in gastrointestinal dysfunction in acute high altitude
[0061] 20 healthy Han nationality subjects without underlying diseases were selected, all of whom were male and first-time entering the plateau. Adult males aged 18-35 years; height 175±15 cm; weight 70±10 kg; born in plain (below 500 meters above sea level) and healthy in physical examination.
[0062] The subjects were divided into a control group and a navel patch group, the control group used a matrix navel patch (microneedle patch without adding traditional Chinese medicine preparation), and the navel patch group used the navel patch prepared in Example 2, 10 people in each group. The subjects in each group were given the drug 1 day before going to the plateau, and the drug was given continuously for 7 days. The navel patch was used every night at 22:00; the navel patch was used once every two days after entering the plateau. After 3 months, the feces were taken for intestinal flora 16S RNA detection, and T test was used to detect the difference flora. The results are shown in Figures 5-7 After analysis, the intestinal flora of various Streptococcus and Bacillus appeared different changes after using the navel patch. The high altitude acute gastrointestinal stress reaction self-rating score table was used to score and analyze the two groups of people, and the navel patch group had less diarrhea, constipation, anorexia and other symptoms, and the mental symptoms such as insomnia and anxiety were relieved to a certain extent, indicating that the navel patch can adjust the intestinal flora to improve the intestinal emergency symptoms caused by the plateau, and can also alleviate other mental symptoms caused by the plateau reaction.
[0063] The above embodiments of the present application are described in detail, but the content described is only the preferred embodiments of the present application, and cannot be considered as limiting the scope of the present application. Any equivalent changes and improvements made according to the scope of the present application should still belong to the patent coverage of the present application.
Claims
1. A formulation for use in gastrointestinal dysfunction in rapid ascent to high altitude, characterized in that: The composition comprises Radix Astragali 25-35g, Radix Codonopsis 10-20g, Rhizoma Atractylodis Macrocephalae 10-20g, Angelica sinensis 8-12g, Cimicifuga foetida 8-12g, Bupleurum falcatum 8-12g, Pericarpium Citri Reticulatae 8-12g, Radix Glycyrrhizae 8-12g, and the preparation comprises active ingredients extracted from the composition.
2. The formulation as claimed in claim 1 for gastrointestinal dysfunction in rapid ascent to high altitude, wherein: The active ingredients of the composition are made into an umbilical patch preparation or an oral-umbilical patch combined preparation.
3. A process for the preparation of the preparation for use in gastrointestinal disorders of high altitude sickness as claimed in claim 1 or 2, wherein: The raw materials of the composition are weighed by weight, mixed, and then concentrated to obtain the formula granules. Or the raw materials of the composition are weighed by weight, mixed, and then crushed, and the active ingredients of the formula are obtained by supercritical carbon dioxide fluid extraction, and the extracted product is mixed with excipients to prepare an oral preparation.
4. The process for preparation of a formulation for gastrointestinal dysfunction in rapid ascent to high altitude as claimed in claim 3 wherein: The extracted product is made into an umbilical patch preparation.
5. The process for preparation of a formulation for gastrointestinal dysfunction in rapid ascent to high altitude as claimed in claim 4 wherein: The extracted product is mixed with a gel to prepare a microneedle patch.
6. Use of the preparation for gastrointestinal dysfunction in rapid ascent to high altitude according to claim 1 or 2 in the preparation of a drug for gastrointestinal dysfunction in rapid ascent to high altitude.
7. Use according to claim 6, characterized in that: It can regulate intestinal flora.
